For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
HomeInterim evaluation of the innovative health initiative (IHI) and final evaluation of the innovative medicines initiative (IMI2)
Evaluation support study on Horizon Europe’s contribution to a Resilient Europe
Publication metadata
This report presents the interim evaluation of the Innovative Health Initiative (IHI) and the final evaluation of its predecessor, the Innovative Medicines Initiative (IMI2). The evaluation considers the programmes’ relevance, coherence, efficiency, effectiveness, EU-added value, as well as their additionality, directionality, international positioning and visibility, and transparency and openness, and presents lessons learned and suggestions for improvement. This study is one of several studies in support of the European Commission’s ex post evaluation of the European Framework Programme for Research and Innovation Horizon 2020 and the interim evaluation of its successor framework programme Horizon Europe.
- Published:
- Themes: Medical and biological research
- Subject: added value , EU initiative , EU research policy , Framework Programme for Research and Development , innovation , medical research , patient , pharmaceutical industry , report , research and development , research expenditure (EU) , research programme , scientific cooperation
|
PDF
|
|||
| ISSN | ISBN 978-92-68-20064-3 | DOI 10.2777/918737 | Catalogue number KI-05-24-626-EN-N |
- Released on EU publications website:
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages